Home The Word Brain	My Amedeo FAQ Privacy About
	C49 + CC Journal Club For more information, please refer to our special emails from April 13 and May 19.

Neoplasms of the CNS

Free Subscription 19.05.2025 1 BMC Cancer 1 BMC Neurol 2 Childs Nerv Syst 2 Clin Neuropathol 1 Int J Radiat Oncol Biol Phys 5 J Neurooncol 1 J Neuropathol Exp Neurol 1 J Neurosurg 7 Neuro Oncol 1 Neuroradiology 1 Neurosurgery 7 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. WANG Y, Qiao S, Wang P, Li M, et al
   Copper's new role in cancer: how cuproptosis-related genes could revolutionize glioma treatment.
   BMC Cancer. 2025;25:859.
   PubMed         Abstract available
   
   

   
   BMC Neurol

2. AZAB MA, Atallah O, Hazim A, El-Gohary N, et al
   Pineal cyst apoplexy in a pregnant female: case report and review of literature.
   BMC Neurol. 2025;25:206.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

3. ERDOGAN O, Eroksuz M, Sahin Y, Gedik B, et al
   Epidural seeding in medulloblastoma: A rare presentation of tumor seeding.
   Childs Nerv Syst. 2025;41:181.
   PubMed         Abstract available
   
   
4. CAVALHEIRO S, Quiroz JAR, Dastoli PA, Kim IHT, et al
   Aqueductal glioma surgery via a telovelar approach using sodium fluorescein in a 6-year-old pediatric patient.
   Childs Nerv Syst. 2025;41:177.
   PubMed         Abstract available
   
   

   
   Clin Neuropathol

5. QUINOT V, Herta J, Stiglbauer-Tscholakoff A, Kiefer FW, et al
   Synchronous pituitary neuroendocrine tumors (PitNETs)/adenomas of triple SF1/PIT1/TPIT cell lineages with multiple hormone expression.
   Clin Neuropathol. 2025;44:55-62.
   PubMed         Abstract available
   
   
6. LIN J, Ung TH, Davies KD, Turin CG, et al
   Clinical and molecular assessment of cystic sellar salivary gland-like lesions.
   Clin Neuropathol. 2025;44:44-54.
   PubMed         Abstract available
   
   

   
   Int J Radiat Oncol Biol Phys

7. FARISELLI L, Marzoli SB, Morlino S, Pinzi V, et al
   Hypofractionated radiosurgery (25 Gy/5 fractions) for optic nerve sheath meningiomas: results from an exploratory phase 2 prospective trial.
   Int J Radiat Oncol Biol Phys. 2025 May 9:S0360-3016(25)00432.
   PubMed         Abstract available
   
   

   
   J Neurooncol

8. SHUKLA IY, Ebada A, Bever N, Traylor JI, et al
   Prognostic value of MIB-1 index in meningioma: a retrospective cohort study to establish an optimal cutoff for recurrence and survival.
   J Neurooncol. 2025 May 12. doi: 10.1007/s11060-025-05057.
   PubMed         Abstract available
   
   
9. WEIDL D, Capper D, Onken J, Liu I, et al
   Epidemiology of WHO grade 2 and grade 3 gliomas from 2009 to 2021 in Germany.
   J Neurooncol. 2025 May 13. doi: 10.1007/s11060-025-05068.
   PubMed         Abstract available
   
   
10. IYER HG, Ariwodo OK, Mckevitt C, Meade PS, et al
    Predictors of return to work following surgery in patients with glioblastoma: a retrospective multicenter study.
    J Neurooncol. 2025 May 13. doi: 10.1007/s11060-025-05066.
    PubMed         Abstract available
    
    
11. BOMMIREDDY A, Mayo ZS, Reddy CA, Billena C, et al
    Development of a recursive partitioning analysis for prediction of radiation necrosis following single-fraction stereotactic radiosurgery for intact brain metastases.
    J Neurooncol. 2025 May 13. doi: 10.1007/s11060-025-05062.
    PubMed         Abstract available
    
    
12. ALDEEVA IA, Glebova EV, Sarkisyan RA, Romanova EN, et al
    Long-term neurocognitive sequelae in pediatric medulloblastoma survivors treated according to the HIT protocol.
    J Neurooncol. 2025 May 16. doi: 10.1007/s11060-025-05070.
    PubMed         Abstract available
    
    

    
    J Neuropathol Exp Neurol

13. FURUTA T, Miyoshi H, Moritsubo M, Nakajima R, et al
    Biological role and clinicopathological significance of leucine-rich alpha-2 glycoprotein 1 in the glioblastoma microenvironment.
    J Neuropathol Exp Neurol. 2025 May 9:nlaf049. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Neurosurg

14. OI Y, Kawabe T, Ogawa T, Taniyama I, et al
    A propensity score-matched analysis of stereotactic radiotherapy for metastatic brain tumors using the Leksell Gamma Knife Icon Mask system: a single-center retrospective comparative study of cases meeting and not meeting the JLGK0901 Criteria.
    J Neurosurg. 2025 May 9:1-10. doi: 10.3171/2025.1.JNS242424.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

15. HAI L, Friedel D, Hinz F, Hoffmann DC, et al
    Distinct epigenetic and transcriptional profiles of Epstein-Barr virus-positive and negative primary CNS lymphomas.
    Neuro Oncol. 2025;27:979-992.
    PubMed         Abstract available
    
    
16. GHOSH HS, Patel RV, Claus EB, Gonzalez Castro LN, et al
    Canonical amplifications and CDKN2A/B loss refine IDH1/2-mutant astrocytoma prognosis.
    Neuro Oncol. 2025;27:993-1003.
    PubMed         Abstract available
    
    
17. QIU J, Zhao R, Ma C, Wang Q, et al
    O-GlcNAcylation stabilized WTAP promotes GBM malignant progression in an N6-methyladenosine-dependent manner.
    Neuro Oncol. 2025;27:900-915.
    PubMed         Abstract available
    
    
18. SUN N, Chen Q, Chen H, Sun P, et al
    A novel nuclear RNA HSD52 scaffolding NONO/SFPQ complex modulates DNA damage repair to facilitate temozolomide resistance.
    Neuro Oncol. 2025;27:963-978.
    PubMed         Abstract available
    
    
19. MARTIN B, Guadix SW, Sathian R, Laramee M, et al
    Designing a time-dependent therapeutic strategy using CDK4/6 inhibitors in an intracranial ATRT model.
    Neuro Oncol. 2025;27:1076-1091.
    PubMed         Abstract available
    
    
20. SCHMID S, Mirchia K, Tietze A, Liu I, et al
    VGLL fusions define a new class of intraparenchymal central nervous system schwannoma.
    Neuro Oncol. 2025;27:1031-1045.
    PubMed         Abstract available
    
    
21. SOBRAL LM, Walker FM, Madhavan K, Janko E, et al
    Targeting processive transcription for Myc-driven circuitry in medulloblastoma.
    Neuro Oncol. 2025 May 15:noaf121. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neuroradiology

22. AHMADZADEH AM, Broomand Lomer N, Ashoobi MA, Elyassirad D, et al
    MRI-derived deep learning models for predicting 1p/19q codeletion status in glioma patients: a systematic review and meta-analysis of diagnostic test accuracy studies.
    Neuroradiology. 2025 May 15. doi: 10.1007/s00234-025-03631.
    PubMed         Abstract available
    
    

    
    Neurosurgery

23. ELBAROODY M, Dokhan M, Kassay A, Ezzat AAM, et al
    Letter: Commentary: Is It Justified to Sacrifice the Pituitary Stalk During Craniopharyngioma Surgery? A Systematic Review and Meta-Analysis.
    Neurosurgery. 2025 May 15. doi: 10.1227/neu.0000000000003510.
    PubMed        
    
    

    
    PLoS One

24. TIAN H, Chu X, Guan Q, Liu J, et al
    Hypotaurine promotes glioma cell invasion by hypermethylating the Wnt5a promoter.
    PLoS One. 2025;20:e0312055.
    PubMed         Abstract available
    
    
25. DENG K, Wen Q, Yang F, Ouyang H, et al
    OS-DETR: End-to-end brain tumor detection framework based on orthogonal channel shuffle networks.
    PLoS One. 2025;20:e0320757.
    PubMed         Abstract available
    
    
26. META R, Pettersen HS, Tollefsen SE, Ytterhus B, et al
    Tumour-associated macrophages in human meningiomas.
    PLoS One. 2025;20:e0319960.
    PubMed         Abstract available
    
    
27. XU C, Shao C, Wang J, Ding X, et al
    Association between anthropometric factors and meningioma risk: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0323461.
    PubMed         Abstract available
    
    
28. 
    Retraction: Evaluating the effect of therapeutic stem cells on TRAIL resistant and sensitive medulloblastomas.
    PLoS One. 2025;20:e0324472.
    PubMed        
    
    
29. WONG Y, Su ELM, Yeong CF, Holderbaum W, et al
    Brain tumor classification using MRI images and deep learning techniques.
    PLoS One. 2025;20:e0322624.
    PubMed         Abstract available
    
    
30. SU YF, Tsai TH, Kuo KL, Wu CH, et al
    Mitochondrial dysfunction and cell death induced by Toona sinensis leaf extracts through MEK/ERK signaling in glioblastoma cells.
    PLoS One. 2025;20:e0320849.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

31. 
    Correction to Supporting Information for Jensen et al., Bcl2L13 is a ceramide synthase inhibitor in glioblastoma.
    Proc Natl Acad Sci U S A. 2025;122:e2507673122.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.